SCHEMBL7515319

SCHEMBL7515319

Cc1ccc(S(=O)(=O)c2[nH]c3ccccc3c2B(O)O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.52
SRC P12931 1/20 0.52
ALDH1A1 P00352 2/20 0.45
IDO1 P14902 1/20 0.45
TDO2 P48775 1/20 0.45
PTGS2 P35354 2/20 0.45
CNR1 P21554 1/20 0.43
TDP1 Q9NUW8 2/20 0.42
LMNA P02545 2/20 0.42
MAPT P10636 2/20 0.42
HTT P42858 2/20 0.42
KDM4E B2RXH2 1/20 0.42
GAA P10253 1/20 0.41
THRB P10828 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
TUBB4A P04350 1/20 0.39
TUBB P07437 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2302449 0.88 TUBB4A (0.42) EGFRSRCALDH1A1PTGS2CNR1
SCHEMBL5960508 0.78 EGFR (0.56) EGFRSRCALDH1A1IDO1TDO2
SCHEMBL4189420 0.78 EGFR (0.56) EGFRSRCALDH1A1IDO1TDO2
SCHEMBL6166809 0.77 EGFR (0.55) EGFRSRCALDH1A1IDO1TDO2
SCHEMBL9051693 0.77 EGFR (0.66) EGFRSRCALDH1A1IDO1TDO2
SCHEMBL29414726 0.77 EGFR (0.51) EGFRSRCALDH1A1IDO1TDO2
SCHEMBL29484406 0.74 EGFR (0.48) EGFRSRCALDH1A1IDO1TDO2
SCHEMBL29484405 0.74 EGFR (0.48) EGFRSRCALDH1A1IDO1TDO2
SCHEMBL8780773 0.71 CNR1 (0.51) EGFRSRCALDH1A1PTGS2CNR1
Carbazole SCHEMBL1352178 0.71 EGFR (0.54) EGFRSRCALDH1A1IDO1TDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP disclosed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP disclosed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO disclosed